地尔硫卓联合生脉注射液治疗高原肺心病的临床观察  

Diltiazem combined with shengmai injection in the treatment of pulmonary heart disease in tableland areas

作　　者：甘国钧 王仲恺 张羚[1] 马秀英 

机构地区：[1]安徽省马鞍山十七冶医院心内科,243000 [2]安徽省马鞍山十七冶医院院长室,243000 [3]四川省松潘县医院内科,623300

出　　处：《淮海医药》2012年第4期308-309,共2页Journal of Huaihai Medicine

摘　　要：目的观察地尔硫卓联合生脉注射液在治疗高原地区慢性肺源性心脏病的临床疗效。方法将入选患者分为治疗组32例,对照组30例。2组均给予抗感染、解痉、平喘、止咳、祛痰、利尿及持续或间断低流量吸氧和对症处理;治疗组同时加用生脉注射液20 ml溶于5%葡萄糖100 ml中缓慢静脉输注,1次/d,7d为1个疗程;地尔硫卓30mg,3次/d,20 d为1个疗程。结果治疗组疗效优于对照组,差异有统计学意义(P<0.05)。结论地尔硫卓联合生脉注射液治疗高原地区慢性肺源性心脏病有一定疗效,值得临床推广应用。Objective To observe the clinical effect of diltiazem combined with shengmai injection in the treatment of pulmonary heart disease in tableland areas.Methods The selected patients were divided into two groups：32 cases in the treatment group and 30 in the control group.Both groups underwent treatment of anti-infection,convulsion alleviation,dyspnea relieving,cough dropping,expectoration,diuretic taking,and continuous or interval low-flow oxygen uptakes as well as some symptomatic treatments.The treatment group also received intravenous drip of 20 ml shengmai injection resolved in 100 ml dextrose of 5% once every day.Each course of treatment lasted 7 days.They also received drip of 30mg diltiazem three times a day and one course of treatment lasted 20 days.Results The result of the patients in the treatment group was better than that in the control group,with significant difference（P〈0.05）.Conclusion Diltiazem combined with shengmai injection for the treatment of pulmonary heart disease in tableland areas has some clinical effect,which is worthy of clinical recommendation and application.

关 键 词：地尔硫卓 生脉注射液 高原 肺心病 治疗结果 

分 类 号：R541.5[医药卫生—心血管疾病]